{"slideshow_credits": null, "snippet": "The sector\u2019s resurgence has been attributed to the stabilization of earnings in big pharmaceutical companies and a shift in perceptions of biotech.", "abstract": "Exchange-traded funds have benefited so far in 2015 from health care companies, which have gained some 7 percent in otherwise flat quarter; analysts attribute sector's resurgence to drop-off in patent expirations, stabilized earnings and increasing confidence in biotech.", "section_name": "Business Day", "print_page": "15", "document_type": "article", "byline": {"person": [{"lastname": "LIM", "rank": 1, "firstname": "Paul", "role": "reported", "organization": "", "middlename": "J."}], "original": "By PAUL J. LIM", "contributor": ""}, "web_url": "http://www.nytimes.com/2015/04/12/business/mutfund/this-quarters-elixir-health-care.html", "lead_paragraph": "The sector\u2019s resurgence has been attributed to the stabilization of earnings in big pharmaceutical companies and a shift in perceptions of biotech.", "headline": {"main": "Health Care Has Been This Quarter\u2019s Elixir for Stock Funds", "print_headline": "This Quarter\u2019s Elixir: Health Care"}, "_id": "5528f83b38f0d855b3a952ea", "word_count": "1010", "multimedia": [{"height": 126, "url": "images/2015/04/12/business/12-HEALTH-1/12-HEALTH-1-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2015/04/12/business/12-HEALTH-1/12-HEALTH-1-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 75, "url": "images/2015/04/12/business/12-HEALTH-1/12-HEALTH-1-thumbStandard.jpg", "legacy": {"thumbnail": "images/2015/04/12/business/12-HEALTH-1/12-HEALTH-1-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2015-04-12T00:00:00Z", "source": "The New York Times", "news_desk": "SundayBusiness", "keywords": [{"name": "subject", "value": "Exchange Traded Funds", "is_major": "Y", "rank": "1"}, {"name": "subject", "value": "Mutual Funds", "is_major": "N", "rank": "2"}, {"name": "subject", "value": "Biotechnology and Bioengineering", "is_major": "Y", "rank": "3"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "4"}, {"name": "subject", "value": "Medicine and Health", "is_major": "N", "rank": "5"}, {"name": "subject", "value": "Standard & Poor's 500-Stock Index", "is_major": "N", "rank": "6"}, {"name": "subject", "value": "Stocks and Bonds", "is_major": "N", "rank": "7"}], "blog": [], "subsection_name": "Mutual Funds", "type_of_material": "News"}